1. Wang, Xianyan, Li, Hongmei, Zhang, Ning, Wu, Tian, Wang, Shaoqing. 2022. FGFR2-CCDC6 fusion gene promotes the proliferation of Hucct-1 cells. In Cellular and molecular biology (Noisy-le-Grand, France), 68, 130-134. doi:10.14715/cmb/2022.68.6.21. https://pubmed.ncbi.nlm.nih.gov/36227665/
2. Zingg, Daniel, Bhin, Jinhyuk, Yemelyanenko, Julia, Wessels, Lodewyk F A, Jonkers, Jos. 2022. Truncated FGFR2 is a clinically actionable oncogene in multiple cancers. In Nature, 608, 609-617. doi:10.1038/s41586-022-05066-5. https://pubmed.ncbi.nlm.nih.gov/35948633/
3. Minashi, Keiko, Yamada, Takeshi, Hosaka, Hisashi, Sakai, Yoshinori, Shitara, Kohei. . Cancer-related FGFR2 overexpression and gene amplification in Japanese patients with gastric cancer. In Japanese journal of clinical oncology, 51, 1523-1533. doi:10.1093/jjco/hyab104. https://pubmed.ncbi.nlm.nih.gov/34258618/
4. Beri, Nina. 2022. Unmet needs in the treatment of intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements. In Future oncology (London, England), 18, 1391-1402. doi:10.2217/fon-2021-1089. https://pubmed.ncbi.nlm.nih.gov/35081733/
5. Goyal, Lipika, Shi, Lei, Liu, Leah Y, Corcoran, Ryan B, Bardeesy, Nabeel. 2019. TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma. In Cancer discovery, 9, 1064-1079. doi:10.1158/2159-8290.CD-19-0182. https://pubmed.ncbi.nlm.nih.gov/31109923/
6. Jahan, Nusrat, Begum, Mobashera, Barek, Md Abdul, Abdulabbas, Hadi Sajid, Islam, Mohammad Safiqul. 2023. Evaluation of the Association between FGFR2 Gene Polymorphisms and Breast Cancer Risk in the Bangladeshi Population. In Genes, 14, . doi:10.3390/genes14040819. https://pubmed.ncbi.nlm.nih.gov/37107577/
7. Haworth, Kim E, Farrell, William E, Emes, Richard D, Mein, Charles, Fryer, Anthony A. . Methylation of the FGFR2 gene is associated with high birth weight centile in humans. In Epigenomics, 6, 477-91. doi:10.2217/epi.14.40. https://pubmed.ncbi.nlm.nih.gov/25431941/
智鼠故事 
